January 2017 Briefing - AllergyLast Updated: February 01, 2017.
Here are what the editors at HealthDay consider to be the most important developments in Allergy for January 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Strategies Presented for Addressing Uncompensated Time
THURSDAY, Jan. 26, 2017 (HealthDay News) -- Strategies can be employed to help physicians deal with the increasing burden of uncompensated tasks, according to an article published in Medical Economics.
Most PCPs Oppose Complete Repeal of the Affordable Care Act
THURSDAY, Jan. 26, 2017 (HealthDay News) -- A majority of primary care doctors oppose full repeal of the Affordable Care Act, according to a perspective piece published online Jan. 25 in the New England Journal of Medicine.
Verapamil Benefits Chronic Rhinosinusitis With Nasal Polyps
THURSDAY, Jan. 26, 2017 (HealthDay News) -- For patients with chronic rhinosinusitis with nasal polyps (CRSwNP), the first-generation inhibitor of epithelial P-glycoprotein (P-gp; an efflux pump that is overexpressed in CRSwNP), verapamil hydrochloride (HCl), is associated with improvement in outcome measures, according to a letter to the editor study published online Jan. 23 in the Journal of Allergy and Clinical Immunology.
Atopic Dermatitis Linked to Risk of Alopecia Areata, Vitiligo
TUESDAY, Jan. 24, 2017 (HealthDay News) -- Atopic dermatitis (AD) is associated with increased risk of alopecia areata (AA) and vitiligo, according to research published online Jan. 18 in Allergy.
Obesity Underrepresented in Medical Licensing Exams
FRIDAY, Jan. 20, 2017 (HealthDay News) -- The most important concepts of obesity prevention and treatment are not adequately represented on the U.S. Medical Licensing Examination (USMLE) Step examinations, according to a study published recently in Teaching and Learning in Medicine.
Increased Risk of Obesity for Children With Asthma
FRIDAY, Jan. 20, 2017 (HealthDay News) -- The risk of developing obesity during childhood and adolescence is increased for children with asthma, according to a study published online Jan. 20 in the American Journal of Respiratory and Critical Care Medicine.
Current Asthma Ruled Out for One-in-Three Diagnosed Adults
TUESDAY, Jan. 17, 2017 (HealthDay News) -- About one-third of adults with a history of physician-diagnosed asthma within the past five years have no evidence of asthma, according to a study published in the Jan. 17 issue of the Journal of the American Medical Association.
Physician Excess Charges Create Financial Burden for Patients
TUESDAY, Jan. 17, 2017 (HealthDay News) -- Many doctors bill their private-paying patients two, three, even six times more than what Medicare pays for the same services, according to a research letter published in the Jan. 17 issue of the Journal of the American Medical Association.
Allergy Diary Phone App Classifies Phenotypes in Rhinitis
FRIDAY, Jan. 13, 2017 (HealthDay News) -- The Allergy Diary phone app can identify phenotypic differences between rhinitis groups, according to a study published online Jan. 10 in Allergy.
Excessive FDA Regulation Driving High Drug Prices
WEDNESDAY, Jan. 11, 2017 (HealthDay News) -- The excessive regulatory regime at the U.S. Food and Drug Administration is an important driver of high drug prices, and should be curbed to introduce more competition and lower prices, according to a report published online Jan. 5 by the National Center for Policy Analysis.
Acid Suppression in Pregnancy Linked to Childhood Asthma
TUESDAY, Jan. 10, 2017 (HealthDay News) -- Women who take acid-suppressing medications during pregnancy may have a child at increased risk of developing asthma, according to a review published online Jan. 9 in the Journal of Allergy and Clinical Immunology.
Ivermectin Has Topical Anti-Inflammatory Properties
MONDAY, Jan. 9, 2017 (HealthDay News) -- Ivermectin (IVM) has anti-inflammatory properties that could be beneficial in treatment of T-cell mediated skin inflammatory diseases, according to an experimental study published online Jan. 4 in Allergy.
Exercise + Weight Loss Improves Asthma Control in Obese
FRIDAY, Jan. 6, 2017 (HealthDay News) -- For obese patients with asthma, adding exercise to a weight-loss program results in improved clinical control, according to a study published in the Jan. 1 issue of the American Journal of Respiratory and Critical Care Medicine.
Food Additives May Play Role in Recurrent Aphthous Stomatitis
THURSDAY, Jan. 5, 2017 (HealthDay News) -- Food additives may play a role in the etiology of recurrent aphthous stomatitis (RAS), according to a study published online Dec. 30 in the International Journal of Dermatology.
Guidelines Urge Earlier Peanut Intro for High-Risk Infants
THURSDAY, Jan. 5, 2017 (HealthDay News) -- Infants at increased risk for peanut allergy should have peanut-containing foods added to their diets as early as 4 months of age, according to new U.S. clinical guidelines published in the January issue of the Journal of Allergy and Clinical Immunology.
Vitamin D Insufficiency in Infancy Not Linked to Food Allergy
THURSDAY, Jan. 5, 2017 (HealthDay News) -- Vitamin D insufficiency (VDI) at birth or age 6 months is not associated with food allergy at 1 year, according to a study published online Jan. 2 in Allergy.
Interface Between Allergy, Oncology Explored
WEDNESDAY, Jan. 4, 2017 (HealthDay News) -- The interface between allergic responses and oncology is being explored, which may have implications for treatment, according to a European Academy of Allergy and Clinical Immunology position paper published online Dec. 29 in Allergy.
New Model IDs Inflammatory Asthma Without Sputum
WEDNESDAY, Jan. 4, 2017 (HealthDay News) -- A new prediction model identifies eosinophilic asthma without the need for sputum induction, according to a study published online Dec. 28 in Allergy.
|Previous: MRI May Help ID Suicide Risk in Young Bipolar Patients||Next: January 2017 Briefing - Cardiology|
Reader comments on this article are listed below. Review our comments policy.